The US psychedelic industry is at a pivotal moment, moving gradually from clinical trials into early stages of commercialization, but still facing regulatory and societal hurdles. Companies are promising breakthroughs that target the root causes of mental health conditions like depression, potentially enabling limited-dose treatments that could ease pressure on…
London has witnessed the departure of more super-wealthy residents than any city in the world, apart from Moscow, according…
US wine sellers are concerned about President Donald Trump’s tariffs which are set to take effect later on Wednesday.…
China escalated its trade conflict with the United States on Wednesday, announcing that it would increase tariffs on American…
EU trade ministers decided to impose retaliatory duties on certain US imports starting next week. However, they favor negotiations…
Venezuela’s inflation crisis worsened in March 2025, with consumer prices surging 13.1% in a single month, according to the…
US stocks experienced a volatile trading session on Monday, resulting in a significant drop. This occurred as the White House…
China has issued a stern warning to the United States, condemning threats to escalate tariffs and pledging to retaliate…
Bankruptcy filings in Japan reached a concerning 11-year high in fiscal 2024, totaling 10,144, according to a report released…